Us Bancorp \De\ Bausch Health Companies Inc. Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,647 shares of BHC stock, worth $10,409. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,647

Previous 1,460 12.81%

Holding current value

$10,409

Previous $11,000 18.18%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$7.34 - $9.78 $1,372 - $1,828	187 Added 12.81%	1,647 $13,000
Q3 2024 Oct 28, 2024	SELL	$5.22 - $8.26 $2,088 - $3,304	-400 Reduced 21.51%	1,460 $11,000
Q2 2024 Aug 06, 2024	SELL	$6.1 - $10.41 $768 - $1,311	-126 Reduced 6.34%	1,860 $12,000
Q1 2024 May 07, 2024	SELL	$7.77 - $10.61 $4,273 - $5,835	-550 Reduced 21.69%	1,986 $21,000
Q4 2023 Feb 09, 2024	SELL	$6.53 - $8.23 $14,052 - $17,710	-2,152 Reduced 45.9%	2,536 $20,000
Q3 2023 Nov 03, 2023	SELL	$7.69 - $9.71 $49,039 - $61,920	-6,377 Reduced 57.63%	4,688 $38,000
Q2 2023 Aug 09, 2023	SELL	$5.72 - $8.8 $7,590 - $11,677	-1,327 Reduced 10.71%	11,065 $88,000
Q1 2023 May 09, 2023	BUY	$6.28 - $9.85 $4,264 - $6,688	679 Added 5.8%	12,392 $100,000
Q4 2022 Feb 13, 2023	BUY	$6.09 - $7.93 $2,722 - $3,544	447 Added 3.97%	11,713 $73,000
Q3 2022 Oct 27, 2022	SELL	$4.58 - $9.21 $80,772 - $162,427	-17,636 Reduced 61.02%	11,266 $78,000
Q2 2022 Aug 01, 2022	BUY	$7.06 - $23.63 $46,151 - $154,469	6,537 Added 29.23%	28,902 $242,000
Q1 2022 May 11, 2022	BUY	$21.6 - $27.79 $190,101 - $244,579	8,801 Added 64.88%	22,365 $511,000
Q4 2021 Feb 11, 2022	SELL	$23.0 - $29.01 $215,441 - $271,736	-9,367 Reduced 40.85%	13,564 $374,000
Q3 2021 Nov 10, 2021	SELL	$25.04 - $30.06 $312,273 - $374,878	-12,471 Reduced 35.23%	22,931 $638,000
Q2 2021 Aug 05, 2021	SELL	$27.43 - $32.7 $6,116 - $7,292	-223 Reduced 0.63%	35,402 $1.04 Million
Q1 2021 Apr 28, 2021	BUY	$21.37 - $34.38 $244,686 - $393,651	11,450 Added 47.36%	35,625 $1.13 Million
Q4 2020 Feb 04, 2021	SELL	$15.31 - $21.12 $153,589 - $211,875	-10,032 Reduced 29.33%	24,175 $502,000
Q3 2020 Nov 10, 2020	BUY	$14.88 - $20.13 $32,810 - $44,386	2,205 Added 6.89%	34,207 $532,000
Q2 2020 Aug 07, 2020	BUY	$13.31 - $20.51 $68,453 - $105,482	5,143 Added 19.15%	32,002 $585,000
Q1 2020 May 13, 2020	BUY	$12.98 - $30.25 $4,620 - $10,769	356 Added 1.34%	26,859 $417,000
Q4 2019 Feb 04, 2020	BUY	$18.89 - $31.89 $80,981 - $136,712	4,287 Added 19.3%	26,503 $793,000
Q3 2019 Nov 08, 2019	SELL	$20.88 - $25.66 $1,378 - $1,693	-66 Reduced 0.3%	22,216 $485,000
Q2 2019 Aug 13, 2019	BUY	$20.52 - $26.45 $118,195 - $152,352	5,760 Added 34.86%	22,282 $562,000
Q1 2019 May 08, 2019	BUY	$20.23 - $26.29 $4,491 - $5,836	222 Added 1.36%	16,522 $408,000
Q4 2018 Feb 13, 2019	BUY	$17.64 - $28.32 $3,104 - $4,984	176 Added 1.09%	16,300 $301,000
Q3 2018 Nov 01, 2018	BUY	$20.64 - $25.67 $332,799 - $413,903	16,124 New	16,124 $414,000

Others Institutions Holding BHC

# of Institutions

262

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.29B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account